233 Users Online
Automated ESR Analyzers Segmented By Fully-sutomated ESR Analyzers, Semi-automated ESR Analyzers instrument and Consumable product with Portable Automated ESR Analyzers, Bench Top Automated ESR Analyzers Modality
The global revenue from the automated ESR analyzer market stands at US$ 351.8 Mn in 2022, with the global market expected to grow at a CAGR of 4.8% to reach a valuation of approximately US$ 588.7 Mn by the end of 2033.
Market Size (2022)
US$ 351.8 Mn
Projected Market Value (2033)
US$ 588.7 Mn
Global Market Growth Rate (2023-2033)
Market Share of Top 4 Countries
As assessed by Persistence Market Research, instruments hold a market share of around 69.1% in 2022 within the global market. Overall, automated ESR analyzer market sales account for approximately 14.1% revenue share in the global hematology tests market, which was valued at around US$ 2.5 Bn in 2022.
The global market recorded a historic CAGR of 4.1% in the last 6 years from 2016 to 2022.
A typical haematological test called the erythrocyte sedimentation rate can detect and track an increase in the body's inflammatory activity brought on by one or more conditions like autoimmune disease, infections, or malignancies. The ESR is used in conjunction with other tests to identify the presence of elevated inflammatory activity, but it is not specific for any one condition.
Due because of its reproducibility and low cost, the ESR has been employed as a "sickness indicator" for a long time. Various techniques have developed over many years to conduct the test. However, Westergren's discoveries from a century ago serve as the foundation for the reference technique for calculating the ESR put out by the International Committee for Standardization in Haematology.
To reduce the biohazard risk to personnel and shorten the time it takes to perform the ESR, improved automated systems incorporating automatic readers and closed blood collection tubes have been implemented in laboratories.
Among the top 25 most frequently performed laboratory tests is the erythrocyte sedimentation rate (ESR), a widely utilised assay. It still has clinical utility attributable to its ease of use and application for tracking inflammatory, autoimmune, and malignant disorders. In recent years, several novel approaches to measuring the ESR employing erythrocyte aggregation have been developed. In the physiological process of erythrocyte aggregation, red blood cells group together to form the face-to-face, linear rouleaux at a low shear rate.
Shorter turnaround times, less exposure of laboratory staff to biohazards, no need for aliquots and thus more effective use of sample volumes are all benefits of integrating ESR technology into automated systems. On the other hand, it has potential drawbacks, including potentially higher instrumentation costs.
Therefore, automated method produces rapid and precise ESR measurements and exhibit excellent correlation with the traditional Westergreen reference approach. Modern ESR techniques avoid the need for extra dilution, which improves operator safety, streamlines logistical laboratory workflow, and minimizes waste.
Thus, owed to the above-mentioned factors, the global market is likely to show high growth over the coming years at a CAGR of 4.8% and reach a global market size of US$ 588.7 Mn by 2033.
“Opportunities in Emerging Economies and Introduction of Novel Products”
Emerging economies in the Asia-Pacific region, including those in India, China, Thailand, Indonesia, and the Philippines, have a considerable market potential.
A sizable patient base and an increase in the prevalence of infectious diseases present profitable growth prospects for businesses looking to record high revenues in the automated ESR analyzer market.
Therefore, increased investments by manufacturers and new players for the introduction of technologically advanced medical equipment is dramatically expanding their global footprint. For instance, the 2020 release of the Aerospray Cytology Slide Stainer Cytocentrifuge by ELITechGroup's Staining Technology, a device that accomplishes two tasks-sample preparation by cytocentrifugation and sample staining-has increased market potential.
There are many untreated patients in emerging economies. These regions provide manufacturers a sizable window of opportunity. According to estimates, sustainability will be aided by economic growth in these developing nations and patients' rising disposable income.
Additionally, it is predicted that an increase in the amount of money that various governments spend on healthcare will encourage diagnostic laboratories to use automated ESR analyzers. It is anticipated that this will increase demand for automated ESR analyzers.
Moreover, it is projected that favourable reimbursement policies, the introduction of automated ESR analysers, and growing healthcare infrastructure in emerging nations will catalyse market demand throughout the projection period.
Even though the Westergren method is the most accurate way to determine ESR, it is difficult, time-consuming, and necessitates a large number of blood samples. Several automated ESR measurement devices are now available to address these problems.
These unique technologies are classified in accordance with the ICSH classification criteria as modified Westergren methods when they incorporate certain changes to the Westergren methodology and alternate ESR techniques for those produced utilizing various methodological concepts, such as centrifugation or photometric rheology.
The automated alternative ESR analyzer Caretium XC-A30 is a recent innovation. It is a compact benchtop tool (40 cm 30 cm 20 cm) designed for small to medium-sized laboratories. The analysis time for this technology, which is based on infrared photometric aggregometry, is reduced because results are generated in 30 minutes. Additionally, Caretium XC-A30 is intended to utilize less blood.
Thus, growing healthcare investments and the introduction of novel automated products will propel the market over the forecast period.
“Risk of Infections, and Presence of Erroneous Negative Results”
Before being used in ordinary practise, automated erythrocyte sedimentation rate (ESR) analyzers must undergo comprehensive validation to demonstrate that they are comparable to the standard Westergren method. This is time consuming and requires comparable evaluations for validity.
Additionally, there is a very significant danger of blood borne infection for medical professionals who come into touch with blood samples. Due to unfavourable outcomes, many are turning to alternatives such C-reactive protein, which offers a better signal of inflammation than ESR.
Early on in an inflammatory process, erroneous negative results are caused by the ESR's sluggish response to the acute phase reaction. Adverse medication responses are responsible for around 100,000 deaths annually in the United States.
Automated ESR analyzers are less appealing due to the unfavourable and detrimental effects of ESR caused by the use of certain medicines during therapy, such as oral contraceptives, vitamin A, aspirin, and cortisone, and this is anticipated to impede market expansion.
These factors are expected to impede market growth, over the forecast period.
Why is the U.S. Market Booming?
“Adoption of Advanced Technologies and Rising Strategies to Reduce Healthcare Economic Burden”
The U.S. is set to account for around 34.5% share in the global market in 2023.
The adoption of modern technologies and the consolidation of medical facilities in this region are the primary drivers of market growth.
Several regulatory agencies and governments, particularly in developed economies, are implementing multiple cost-cutting strategies to lower their healthcare burden. Technological advances are clearing the way for the advancement of automated ESR analyzers beyond manual ESR analyzers, propelling the global market.
The increasing availability of automated ESR analyzers with advanced and novel technologies has boosted laboratory workflow while also improving turnaround time, which is another key reason driving global usage of automated ESR analyzers in the country.
Will Germany Be a Lucrative Market for Automated ESR Analyzer?
“High Prevalence of Cancer”
Germany is set to hold around 7.3% share of the global market in 2023.
Because of its considerable share of the global cancer burden, Europe is an important focus for obtaining accurate and up-to-date global cancer data. Because ESR analyzers are associated with the symptoms of current malignancies, it is quite likely that demand for automated ESR analyzers will remain strong in Germany as cancer prevalence rises. Furthermore, due to illnesses such as infection, inflammation, heart disease, blood disease, diabetes, and collagen vascular disease, automated ESR analyzers will continue to be in high demand.
How is Japan Emerging as a Prominent Market?
“Development of Fully Automated Laboratory Systems”
Japan is set to hold a market share of about 9.4% of the global market in 2023.
With the advent of full automation of laboratory systems within the Asia Pacific region, Japan holds a larger share within the global market. This is attributed to the large geriatric population bringing in a heavy disease burden associated with age-related disorders. Moreover, presence of established medical device manufacturers within the country also propel the share of Japan within the global market over the forecast period.
Which Product is Driving Demand within the Global Market?
“Greater Efficacy and Small Sample Requirement”
Instruments held around 69.1% of the total market in 2022. When an instrument is fully automated from the moment a sample tube is inserted, it can be used walk-away. This is the case with fully-automated ESR analyzers.
These instruments span a wide range of channels depending on the capacity needed, enabling use across numerous end-use scenarios. Modern fully automated analyzers require small sample quantities, making them ideal for testing paediatric samples.
Moreover, with semi-automated analyzers, sampling is carried out manually for equipment that use an external needle and uncapped tubes. These instruments have a few benefits, such as a reduced size that enables use in confined locations and fewer moving components that reduce the need for maintenance and/or repairs.
Owed to these advantages, instruments hold a larger share within the global market.
Which Modality is Largely Preferred within the Global Market?
“Short Analysis Times and Portability”
Portable automated ESR analyzer held around 73.3% of the total market in 2022. Portable ESR analyzers are portable devices that use the infrared sensor measurement concept and the Westergren analysis method. They can process up to 80 samples per hour while offering a measuring range of 1 to 140 mm/h. The majority of devices feature a maximum simultaneous sample loading capacity of 40 and two measuring durations of 30 or 60 minutes.
Reduced analysis time, as well as minimal special requirements allow this segment to hold a dominant share within the global market.
How will Analysis Time Influence Market Growth?
“Patient Identification and Faster Sampling Times”
The segment with 15-30 min of analysis held around 42.5% of the total market in 2022. Automated ESR analyzers, like the Excyte 20 Automated ESR Analyzer from ELITechGroup, may produce results with a high throughput in as little as 15 minutes. Up to 20 samples can be stored in the device, which enables it to conduct up to 80 sed rates each hour. The analyzer maintains information for 30 days of QC and up to 500 patient samples for easy retrieval.
Daily QC may be quickly analysed using Youden Plot graphs, and on-board mixing produces a more reliable mix by ensuring a more constant mix. Using the built-in bar code scanner, patient identification is rapidly scanned and stored, which helps you save time. Due to these advancements, the segment has a bigger market share.
Which End User Provides the Global Market With a Large Share?
“Greater Productivity, Short Turnaround Times, and Enhanced Lab Security”
The diagnostic laboratories segment held a share of about 17.8% in 2022 globally. A lab device called the ESR Analyzer aids in determining how many red blood cells are present in an individual's body. It frequently aids in the diagnosis of diseases like anemia. Erythrocyte sedimentation rate analyzers that are automated enhance productivity, turnaround time, and lab security.
Additionally, simple sedimentation rate assessment and quality monitoring are made possible by customized ESR analyzers. Key factors to take into account are capacity, analysis time, throughput, and dimensions according on the laboratory's needs. These factors will increase product adoption among diagnostic laboratories and make it a dominating end user sector on the global market.
Key competitors in the market for automated ESR analyzers are concentrating on developing new products that can be personalised for various purposes. Product manufacturers are using cutting-edge marketing techniques to increase their market share.
Increased investments in cutting-edge technologies to meet changing research needs; increased emphasis on technological innovation and advancement. Companies are heavily spending in R&D in order to increase their product portfolios and market presence globally, particularly to meet the changing needs of researchers.
Some key instances of development within the market include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the automated ESR analyzer market, which are available in the full report.
Historical Data Available for
USD Million for Value
Key Countries Covered
Key Market Segments Covered
Key Companies Covered
Customization & Pricing
Available upon Request
The global market is currently valued at around US$ 351.8 Mn in 2022.
Sales of the market are set to witness growth at a CAGR of 4.8% and be valued at around US$ 588.7 Mn by 2033.
Demand for the global market increased at a 4.1% CAGR from 2016 to 2022.
The U.S., Germany, Japan, and Australia account for most demand within the market, currently holding around 53.2% market share.
The U.S. is set to account for around 34.5% share of the global market in 2023.
Europe is set to grow at a CAGR growth rate of nearly 4.8% over the forecast period.
The Japan market held a share of about 9.4% in the global market in 2022.
Germany is set to hold around 7.3% share of the global market in 2023.
The China market is expected to grow at 4.0% CAGR during the forecast period.
The market in India is set to expand at a 7.2% CAGR over the forecast period.